Literature DB >> 3047857

Urinary infection stones caused by Ureaplasma urealyticum: a review.

L Grenabo1, H Hedelin, S Pettersson.   

Abstract

Experimental and clinical studies have been performed to determine whether Ureaplasma urealyticum has an etiological role in the development of infection stones in the urinary tract. Incubation of synthetic urine in vitro with U. urealyticum caused alkalinization of the urine and crystallization of struvite and calcium phosphate. Inoculation of U. urealyticum into rat bladders resulted in the formation of struvite stones in 84% of the rats. Furthermore, infection with U. urealyticum markedly increased the adherence of urease-induced crystals to the bladder epithelium compared to normal rat bladders, probably due to elimination of the mucous coat which covers the normal urothelium. Clinically, U. urealyticum has been cultured from voided urine and from the stone in patients operated on for renal stones. U. urealyticum was cultured in voided urine in 31 of 247 patients (13%) with metabolic stones, compared to 43 of 145 patients (30%) with infection stones (p less than 0.001). In the patients where stone cultures were performed, U. urealyticum was found in 2 of 125 patients (2%) with metabolic stones, compared to 10 of 64 patients (16%) with infection stones (p less than 0.001). These observations strongly suggest that U. urealyticum is linked to the formation of infection stones in the urinary tract.

Entities:  

Mesh:

Year:  1988        PMID: 3047857

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  6 in total

Review 1.  Controversies in the laboratory diagnosis of community-acquired urinary tract infection.

Authors:  M G Morgan; H McKenzie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

2.  Rat strains differ in susceptibility to Ureaplasma parvum-induced urinary tract infection and struvite stone formation.

Authors:  Leticia Reyes; Mary Reinhard; L J O'donell; Janet Stevens; Mary B Brown
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 3.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.

Authors:  K Nagata; E Takagi; H Satoh; H Okamura; T Tamura
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

5.  Cytological Features Associated with Ureaplasma Urealyticum in Pap Cervical Smear

Authors:  Mitsuaki Okodo; Jumpei Kawamura; Kaori Okayama; Kenji Kawai; Tadasi Fukui; Natsuko Shiina; Timothy Caniz; Hiromi Yabusaki; Masahiko Fujii
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

Review 6.  Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.

Authors:  Chen Yiwen; Wu Yueyue; Qin Lianmei; Zhu Cuiming; You Xiaoxing
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.